Bemis Latin America has developed printed coldform for Doril Enxaqueca medicine.
Bemis Latin America has developed printed coldform for Doril Enxaqueca medicine. Doril Enxaqueca is the first product to use coldform printed locally in Brazil. With the printed coldform, the entire area of the package, including the formed bubble that accommodates the medicine, can be used for product communication, creating greater exposure of over-the-counter products. The new package also reduces production time and offers a more competitive price to pharmaceutical manufacturers. The use of new special inks in the formed bubble helps resist stretching of the material at the time of the cavities’ formation, eliminating cracking and printing with distortion. As a result of the printable area and coldform protection, the product does not need a folding box, reducing the amount of packaging in the supply chain, further allowing a more competitive price for pharmaceutical manufacturers.